Caplin Point Laboratories Ltd

NSE: CAPLIPOINT · BSE: 524742 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹2,619.70
Market cap: ₹19,913 Cr
Revenue (annual): ₹2,187 Cr
Net profit (annual): ₹641.2 Cr
P/E (TTM): 29.9×Sector 47.4×
Promoter holding: 70.57%+0.00% QoQ
FII holding: 5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Earnings Call 4 Financial Results 3 Regulatory Approval 2 Price Movement Clarification 2 Dividend 2 Business Update 2 Board Meeting Date 2 Annual General Meeting 2 Management Change 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

1 Sep 2026 17:59 IST NSE

Business Update

Caplin Point Laboratories Business Update

Caplin Point Laboratories' subsidiary, Caplin One Labs, received GMP compliance certification from Colombia's INVIMA for its oncology drug manufacturing facility.

Read the filing ↗

21 Aug 2026 19:07 IST BSE

Business Update

Caplin Point Laboratories Business Update

Caplin Point Laboratories completed an unannounced US FDA inspection at its subsidiary's facility. The company received 10 procedural observations and will respond within the stipulated timeframe.

Read the filing ↗